What is it about?

Parvovirus B19 is the virus behind 'fifth disease', a common childhood rash. In adults it often causes no symptoms, but it can be passed on through blood transfusion and be dangerous for pregnant women, people with blood disorders and immunocompromised patients. During the exceptional European B19 wave of 2023-2024, 12 out of 27,737 blood donations collected in Trieste and Gorizia tested positive. We followed these donors for one year. None felt ill when donating, although six later recalled mild symptoms or contact with a sick child. Virus levels in the blood were very high at donation but fell rapidly, dropping below 1,000 IU/mL after about four months; very low levels persisted for longer. Antibodies (IgG) appeared in all donors, while IgM sometimes lasted almost a year.

Featured Image

Why is it important?

Transfusion transmission has been reported even at low viral loads, so our data suggest a theoretical risk window of up to nine months after infection. However, real-world transfusion problems remain rare thanks to widespread immunity in the population. These findings support current policies that do not require routine B19 screening of all donations, while recommending targeted testing for high-risk recipients and a temporary 4-6 month deferral of highly viraemic donors.

Perspectives

This study was born from the daily collaboration between our Transfusion Medicine, Microbiology and Infectious Diseases units in Trieste. Following healthy donors for a full year gave us a rare, detailed picture of B19 kinetics. It shows how a local surveillance signal can be turned into practical evidence for blood safety policies.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Insights into parvovirus B19 clinical and virological dynamics among blood donors, Infezioni in Medicina, June 2026, Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche,
DOI: 10.53854/liim-3402-8.
You can read the full text:

Read

Contributors

The following have contributed to this page